Bellerophon Therapeutics Inc
NASDAQ:BLPH
Bellerophon Therapeutics Inc
Other Long-Term Assets
Bellerophon Therapeutics Inc
Other Long-Term Assets Peer Comparison
Competitive Other Long-Term Assets Analysis
Latest Figures & CAGR of Competitors
Company | Other Long-Term Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Bellerophon Therapeutics Inc
NASDAQ:BLPH
|
Other Long-Term Assets
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Other Long-Term Assets
$2.4B
|
CAGR 3-Years
11%
|
CAGR 5-Years
18%
|
CAGR 10-Years
17%
|
|
Boston Scientific Corp
NYSE:BSX
|
Other Long-Term Assets
$4.5B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
31%
|
CAGR 10-Years
29%
|
|
Stryker Corp
NYSE:SYK
|
Other Long-Term Assets
$3.9B
|
CAGR 3-Years
7%
|
CAGR 5-Years
10%
|
CAGR 10-Years
22%
|
|
Abbott Laboratories
NYSE:ABT
|
Other Long-Term Assets
$7.5B
|
CAGR 3-Years
26%
|
CAGR 5-Years
28%
|
CAGR 10-Years
13%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Other Long-Term Assets
$1.5B
|
CAGR 3-Years
24%
|
CAGR 5-Years
19%
|
CAGR 10-Years
27%
|
See Also
What is Bellerophon Therapeutics Inc's Other Long-Term Assets?
Other Long-Term Assets
0
USD
Based on the financial report for Sep 30, 2023, Bellerophon Therapeutics Inc's Other Long-Term Assets amounts to 0 USD.